Cell Genesys, Inc. has announced that the two companies have entered into an asset sale agreement relating to Cell Genesys' lentiviral gene delivery technology, commonly referred to as lentiviral ...

New partnership creates seamless adoption of smart end-to-end innovations to help joint customers transform their business for the experience economy SAN FRANCISCO, Jan. 12, 2023 /PRNewswire/ -- ...

New partnership creates seamless adoption of smart end-to-end innovations to help joint customers transform their business for the experience economy In today's complex business market, customer and ...

Its gene-activation technology garnered Cell Genesys Inc. a deal worth $26 million in cash and stock with Transkaryotic Therapies Inc., which plans to use the approach with up to 15 therapeutic ...